Abstract
Anticholinergic agents have been used as premedication in digestive endoscopy, and their use is very convenient from a cost-benefit relationship point of view. However, the higher age groups population is increasing all over the world and, along with the older age, the medical treatment of those patients reaches a crucial point. In other words, elderly people often carry different kinds of complications which may hinder the gastrointestinal endoscopic examination. According to our experience, anticholinergic agents were not administered in 7.1% of a total of 10 574 patients examined by endoscopy between 1977 and 1986. On the other hand, when the age group older than 65 years was considered, it was evident that anticholinergics could not have been given to 19.5% of those patients because of contra indications such as glaucoma and prostatic hypertrophy, amongst others (Table 5.1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chernish SM, Miller RE, Rosenak BD, Scholz NE. Hypotonic duodenography with the use of glucagon. Gastroenterology 1972; 63: 392–398.
Miller RE, Chernish SM, Skucas J, Rosenak BD, Rodda BE. Hypotonic roentgenology with glucagon. Am J Roentgenol 1974; 121: 264–274.
Bertrand G, Linscheer WG, Raheja KL, Woods RE. Double-blind evaluation of glucagon and propantheline bromide (Pro-Banthine) for hypotonic duodenography. Am J Roentgenol 1977; 128: 197–200.
Qvigstad T, Larsen S, Myren J. Comparison of glucagon, atropine, and placebo as premedication for endoscopy of the upper gastrointestinal tract. Scand J Gastroenterol 1979; 14: 231–235.
Kawamoto H et al. Effect of glucagon on the upper gastrointestinal motility. Gastroenterol Endosc 1983; 25: 1347.
Stoecker R, Foy D. Improvement of gastric mucosal detail in the double-contrast upper gastrointestinal examination utilizing low-dose glucagon. J Am Osteopath Assoc 1984; 83: 660–662.
Hradsky M, Stockbrügger R, Dotevall G, Ostberg H. The use of glucagon during upper gastrointestinal endoscopy. Gastrointest Endosc 1974; 20: 162.
Giesen HK. Kardiale Nebenwirkungen der Osophago-Gastro-Duodenoskopie in Abhän- gigkeit von der Prämedikation. Dtsch Med Wsch 1978; 103: 1517–1520.
Gerner T, Myren J, Larsen S. Premedication in upper gastrointestinal endoscopy. Scand J Gastroenterol 1983; 18: 925–928.
Taylor I, Duthie HL, Cumberland DC, Smallwood R. Glucagon and the colon. Gut 1975; 16: 973–978.
Chowdhury AR, Lorber SH. Effect of glucagon on cholecystokinin and Prostigmin-induced motor activity of the distal colon and rectum in humans. Gastroenterology 1975; 68: 875.
Chowdhury AR, Dinoso VP, Lorber SH. Characterization of a hyperactive segment at the rectosigmoid junction. Gastroenterology 1976; 71: 584–588.
Chowdhury AR, Lorber SH. Effects of glucagon and secretin on food- or morphine-induced motor activity of the distal colon, rectum, and anal sphincter. Dig Dis 1977; 22: 775–780.
Fujita K et al Manometric study on colonic intraluminal pressure using the endoscopic method. Gastroenterol Endosc 1978; 21: 857.
Editor information
Rights and permissions
Copyright information
© 1987 MTP Press Limited
About this chapter
Cite this chapter
Takemoto, T., Okita, K., Tada, M., Kawano, H., Yoshida, T., Akiyama, T. (1987). Glucagon in digestive endoscopy — its usefulness for premedication. In: Picazo, J. (eds) Glucagon in 1987. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3185-5_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-3185-5_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7929-7
Online ISBN: 978-94-009-3185-5
eBook Packages: Springer Book Archive